Industry Research Reports

Home > Reports > Service & Software > Global Spatial Transcriptomics Platform Market Research Report 2026

Global Spatial Transcriptomics Platform Market Research Report 2026

Industry: Service & Software

Published Date: 2026-07-18

Pages: 113 Pages

Report ld: 6977905

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Spatial Transcriptomics Platform Market Size(US$)

CAGR 2026-2032

14.6%

Market Size,2032

USD 1,185

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 523 million

Market Forecast in 2032(Value)

US$ 1,185 million

CAGR

14.6%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Spatial Transcriptomics Platform market was valued at US$ 455 million in 2025 and is anticipated to reach US$ 1185 million by 2032, at a CAGR of 14.6% from 2026 to 2032.

Spatial transcriptomics platforms combine instruments, reagents and consumables, library-preparation workflows, and software to localize and quantify RNA expression in tissue sections while preserving morphology and spatial coordinates. They mainly use spatial barcoding and sequencing, in situ hybridization imaging, in situ sequencing, or region-of-interest digital profiling, and can provide whole-transcriptome or targeted gene measurements integrated with pathology images, cell segmentation, and protein-marker data. Key purchasing parameters include spatial resolution, transcript coverage, sensitivity, capture area, sample compatibility, throughput per run, automation, and data-analysis capability. Primary users include research institutions, core facilities, biopharmaceutical companies, and translational medicine centers. The blended gross margin is approximately 60%.

Research on tumor microenvironments, brain-region cell atlases, embryonic development, immune inflammation, and drug mechanisms requires gene-expression measurements linked to tissue location. This is moving spatial transcriptomics from small validation experiments toward larger, standardized projects. Growing interest in archived pathology samples and the need for spatial evidence in target discovery, patient stratification, and pharmacodynamic assessment are increasing demand for FFPE-compatible, high-throughput, and reproducible workflows.

Competition centers on spatial resolution, gene plex, transcript-detection sensitivity, effective imaging or capture area, sample compatibility, run time, and cost per sample. Sequencing-based platforms are strongest in whole-transcriptome discovery, while imaging-based platforms emphasize single-cell and subcellular localization. Leading suppliers are integrating instruments, reagents, panel design, image processing, cell segmentation, and cloud analytics into closed workflows. Development priorities include larger tissue areas, higher gene throughput, same-section RNA and protein detection, automated sample handling, and cross-platform data standardization.

North America and Europe continue to concentrate major core facilities, pharmaceutical customers, and premium instrument installations, while China and the wider Asia-Pacific region are expanding through local spatial-omics technologies, sequencing infrastructure, and translational research investment. Opportunities include oncology translational studies, neuroscience, tissue-atlas programs, drug-response databases, and clinical sample cohorts. Key risks include sample-preparation variation, batch effects, data and computing costs, inconsistent analytical algorithms, platform lock-in, and volatility in research budgets.

This report delivers a comprehensive overview of the global Spatial Transcriptomics Platform market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Spatial Transcriptomics Platform. The Spatial Transcriptomics Platform market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Spatial Transcriptomics Platform market comprehensively. Regional market sizes by Type, by Application, by Spatial Resolution, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Spatial Transcriptomics Platform manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

10x Genomics
Bruker
Vizgen
STOmics
Curio Bioscience
Resolve Biosciences
Bio-Techne
Miltenyi Biotec
SeekGene
BMKMANU
CapitalBio Technology
Dynamic Biosystems
M20 Genomics
Singleron Biotechnologies
AtlasXomics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Sequencing-Based Spatial Barcoding Platforms
Imaging-Based in Situ Hybridization Platforms
In Situ Sequencing Platforms
Region-of-Interest Digital Profiling Platforms
Spatial Single-Nucleus Sequencing Platforms
Other or Hybrid Platforms

Segment by Application

Oncology Research
Neuroscience Research
Developmental and Regenerative Biology
Immunology and Infectious Disease
Organ Physiology and Metabolic Disease
Other Life Science Research

Segment by Category

Region-Level Resolution (>100 μm)
Spot-Level Resolution (20–100 μm)
Near-Cellular Resolution (5–<20 μm)
Single-Cell Resolution (1–<5 μm)
Subcellular Resolution (<1 μm)

Segment by Division

Whole-Transcriptome Profiling
Large Targeted Panels (≥1,000 Genes)
Medium Targeted Panels (100–999 Genes)
Small Targeted Panels (<100 Genes)

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Spatial Resolution, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Spatial Transcriptomics Platform companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Spatial Transcriptomics Platform Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Sequencing-Based Spatial Barcoding Platforms

1.2.3 Imaging-Based in Situ Hybridization Platforms

1.2.4 In Situ Sequencing Platforms

1.2.5 Region-of-Interest Digital Profiling Platforms

1.2.6 Spatial Single-Nucleus Sequencing Platforms

1.2.7 Other or Hybrid Platforms

1.3 Market by Spatial Resolution

1.3.1 Global Spatial Transcriptomics Platform Market Size Growth Rate by Spatial Resolution: 2021 vs 2025 vs 2032

1.3.2 Region-Level Resolution (>100 μm)

1.3.3 Spot-Level Resolution (20–100 μm)

1.3.4 Near-Cellular Resolution (5–<20 μm)

1.3.5 Single-Cell Resolution (1–<5 μm)

1.3.6 Subcellular Resolution (<1 μm)

1.4 Market by Transcriptome Coverage

1.4.1 Global Spatial Transcriptomics Platform Market Size Growth Rate by Transcriptome Coverage: 2021 vs 2025 vs 2032

1.4.2 Whole-Transcriptome Profiling

1.4.3 Large Targeted Panels (≥1,000 Genes)

1.4.4 Medium Targeted Panels (100–999 Genes)

1.4.5 Small Targeted Panels (<100 Genes)

1.5 Market by Application

1.5.1 Global Spatial Transcriptomics Platform Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Oncology Research

1.5.3 Neuroscience Research

1.5.4 Developmental and Regenerative Biology

1.5.5 Immunology and Infectious Disease

1.5.6 Organ Physiology and Metabolic Disease

1.5.7 Other Life Science Research

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Spatial Transcriptomics Platform Market Perspective (2021–2032)

2.2 Global Spatial Transcriptomics Platform Growth Trends by Region

2.2.1 Global Spatial Transcriptomics Platform Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Spatial Transcriptomics Platform Historic Market Size by Region (2021–2026)

2.2.3 Spatial Transcriptomics Platform Forecasted Market Size by Region (2027–2032)

2.3 Spatial Transcriptomics Platform Market Dynamics

2.3.1 Spatial Transcriptomics Platform Industry Trends

2.3.2 Spatial Transcriptomics Platform Market Drivers

2.3.3 Spatial Transcriptomics Platform Market Challenges

2.3.4 Spatial Transcriptomics Platform Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Spatial Transcriptomics Platform Players by Revenue

3.1.1 Global Top Spatial Transcriptomics Platform Players by Revenue (2021–2026)

3.1.2 Global Spatial Transcriptomics Platform Revenue Market Share by Players (2021–2026)

3.2 Global Top Spatial Transcriptomics Platform Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Spatial Transcriptomics Platform Revenue

3.4 Global Spatial Transcriptomics Platform Market Concentration Ratio

3.4.1 Global Spatial Transcriptomics Platform Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Spatial Transcriptomics Platform Revenue in 2025

3.5 Global Key Players of Spatial Transcriptomics Platform Head Offices and Areas Served

3.6 Global Key Players of Spatial Transcriptomics Platform, Products and Applications

3.7 Global Key Players of Spatial Transcriptomics Platform, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Spatial Transcriptomics Platform Breakdown Data by Type

4.1 Global Spatial Transcriptomics Platform Historic Market Size by Type (2021–2026)

4.2 Global Spatial Transcriptomics Platform Forecasted Market Size by Type (2027–2032)

5 Spatial Transcriptomics Platform Breakdown Data by Application

5.1 Global Spatial Transcriptomics Platform Historic Market Size by Application (2021–2026)

5.2 Global Spatial Transcriptomics Platform Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Spatial Transcriptomics Platform Market Size (2021–2032)

6.2 North America Spatial Transcriptomics Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Spatial Transcriptomics Platform Market Size by Country (2021–2026)

6.4 North America Spatial Transcriptomics Platform Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Spatial Transcriptomics Platform Market Size (2021–2032)

7.2 Europe Spatial Transcriptomics Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Spatial Transcriptomics Platform Market Size by Country (2021–2026)

7.4 Europe Spatial Transcriptomics Platform Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Spatial Transcriptomics Platform Market Size (2021–2032)

8.2 Asia-Pacific Spatial Transcriptomics Platform Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Spatial Transcriptomics Platform Market Size by Region (2021–2026)

8.4 Asia-Pacific Spatial Transcriptomics Platform Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Spatial Transcriptomics Platform Market Size (2021–2032)

9.2 Latin America Spatial Transcriptomics Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Spatial Transcriptomics Platform Market Size by Country (2021–2026)

9.4 Latin America Spatial Transcriptomics Platform Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Spatial Transcriptomics Platform Market Size (2021–2032)

10.2 Middle East & Africa Spatial Transcriptomics Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Spatial Transcriptomics Platform Market Size by Country (2021–2026)

10.4 Middle East & Africa Spatial Transcriptomics Platform Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 10x Genomics

11.1.1 10x Genomics Company Details

11.1.2 10x Genomics Business Overview

11.1.3 10x Genomics Spatial Transcriptomics Platform Introduction

11.1.4 10x Genomics Revenue in Spatial Transcriptomics Platform Business (2021–2026)

11.1.5 10x Genomics Recent Development

11.2 Bruker

11.2.1 Bruker Company Details

11.2.2 Bruker Business Overview

11.2.3 Bruker Spatial Transcriptomics Platform Introduction

11.2.4 Bruker Revenue in Spatial Transcriptomics Platform Business (2021–2026)

11.2.5 Bruker Recent Development

11.3 Vizgen

11.3.1 Vizgen Company Details

11.3.2 Vizgen Business Overview

11.3.3 Vizgen Spatial Transcriptomics Platform Introduction

11.3.4 Vizgen Revenue in Spatial Transcriptomics Platform Business (2021–2026)

11.3.5 Vizgen Recent Development

11.4 STOmics

11.4.1 STOmics Company Details

11.4.2 STOmics Business Overview

11.4.3 STOmics Spatial Transcriptomics Platform Introduction

11.4.4 STOmics Revenue in Spatial Transcriptomics Platform Business (2021–2026)

11.4.5 STOmics Recent Development

11.5 Curio Bioscience

11.5.1 Curio Bioscience Company Details

11.5.2 Curio Bioscience Business Overview

11.5.3 Curio Bioscience Spatial Transcriptomics Platform Introduction

11.5.4 Curio Bioscience Revenue in Spatial Transcriptomics Platform Business (2021–2026)

11.5.5 Curio Bioscience Recent Development

11.6 Resolve Biosciences

11.6.1 Resolve Biosciences Company Details

11.6.2 Resolve Biosciences Business Overview

11.6.3 Resolve Biosciences Spatial Transcriptomics Platform Introduction

11.6.4 Resolve Biosciences Revenue in Spatial Transcriptomics Platform Business (2021–2026)

11.6.5 Resolve Biosciences Recent Development

11.7 Bio-Techne

11.7.1 Bio-Techne Company Details

11.7.2 Bio-Techne Business Overview

11.7.3 Bio-Techne Spatial Transcriptomics Platform Introduction

11.7.4 Bio-Techne Revenue in Spatial Transcriptomics Platform Business (2021–2026)

11.7.5 Bio-Techne Recent Development

11.8 Miltenyi Biotec

11.8.1 Miltenyi Biotec Company Details

11.8.2 Miltenyi Biotec Business Overview

11.8.3 Miltenyi Biotec Spatial Transcriptomics Platform Introduction

11.8.4 Miltenyi Biotec Revenue in Spatial Transcriptomics Platform Business (2021–2026)

11.8.5 Miltenyi Biotec Recent Development

11.9 SeekGene

11.9.1 SeekGene Company Details

11.9.2 SeekGene Business Overview

11.9.3 SeekGene Spatial Transcriptomics Platform Introduction

11.9.4 SeekGene Revenue in Spatial Transcriptomics Platform Business (2021–2026)

11.9.5 SeekGene Recent Development

11.10 BMKMANU

11.10.1 BMKMANU Company Details

11.10.2 BMKMANU Business Overview

11.10.3 BMKMANU Spatial Transcriptomics Platform Introduction

11.10.4 BMKMANU Revenue in Spatial Transcriptomics Platform Business (2021–2026)

11.10.5 BMKMANU Recent Development

11.11 CapitalBio Technology

11.11.1 CapitalBio Technology Company Details

11.11.2 CapitalBio Technology Business Overview

11.11.3 CapitalBio Technology Spatial Transcriptomics Platform Introduction

11.11.4 CapitalBio Technology Revenue in Spatial Transcriptomics Platform Business (2021–2026)

11.11.5 CapitalBio Technology Recent Development

11.12 Dynamic Biosystems

11.12.1 Dynamic Biosystems Company Details

11.12.2 Dynamic Biosystems Business Overview

11.12.3 Dynamic Biosystems Spatial Transcriptomics Platform Introduction

11.12.4 Dynamic Biosystems Revenue in Spatial Transcriptomics Platform Business (2021–2026)

11.12.5 Dynamic Biosystems Recent Development

11.13 M20 Genomics

11.13.1 M20 Genomics Company Details

11.13.2 M20 Genomics Business Overview

11.13.3 M20 Genomics Spatial Transcriptomics Platform Introduction

11.13.4 M20 Genomics Revenue in Spatial Transcriptomics Platform Business (2021–2026)

11.13.5 M20 Genomics Recent Development

11.14 Singleron Biotechnologies

11.14.1 Singleron Biotechnologies Company Details

11.14.2 Singleron Biotechnologies Business Overview

11.14.3 Singleron Biotechnologies Spatial Transcriptomics Platform Introduction

11.14.4 Singleron Biotechnologies Revenue in Spatial Transcriptomics Platform Business (2021–2026)

11.14.5 Singleron Biotechnologies Recent Development

11.15 AtlasXomics

11.15.1 AtlasXomics Company Details

11.15.2 AtlasXomics Business Overview

11.15.3 AtlasXomics Spatial Transcriptomics Platform Introduction

11.15.4 AtlasXomics Revenue in Spatial Transcriptomics Platform Business (2021–2026)

11.15.5 AtlasXomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Spatial Transcriptomics Platform Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Sequencing-Based Spatial Barcoding Platforms

Table 3. Key Players of Imaging-Based in Situ Hybridization Platforms

Table 4. Key Players of In Situ Sequencing Platforms

Table 5. Key Players of Region-of-Interest Digital Profiling Platforms

Table 6. Key Players of Spatial Single-Nucleus Sequencing Platforms

Table 7. Key Players of Other or Hybrid Platforms

Table 8. Global Spatial Transcriptomics Platform Market Size Growth Rate by Spatial Resolution (US$ Million): 2021 vs 2025 vs 2032

Table 9. Key Players of Region-Level Resolution (>100 μm)

Table 10. Key Players of Spot-Level Resolution (20–100 μm)

Table 11. Key Players of Near-Cellular Resolution (5–<20 μm)

Table 12. Key Players of Single-Cell Resolution (1–<5 μm)

Table 13. Key Players of Subcellular Resolution (<1 μm)

Table 14. Global Spatial Transcriptomics Platform Market Size Growth Rate by Transcriptome Coverage (US$ Million): 2021 vs 2025 vs 2032

Table 15. Key Players of Whole-Transcriptome Profiling

Table 16. Key Players of Large Targeted Panels (≥1,000 Genes)

Table 17. Key Players of Medium Targeted Panels (100–999 Genes)

Table 18. Key Players of Small Targeted Panels (<100 Genes)

Table 19. Global Spatial Transcriptomics Platform Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 20. Global Spatial Transcriptomics Platform Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 21. Global Spatial Transcriptomics Platform Market Size by Region (US$ Million), 2021–2026

Table 22. Global Spatial Transcriptomics Platform Market Share by Region (2021–2026)

Table 23. Global Spatial Transcriptomics Platform Forecasted Market Size by Region (US$ Million), 2027–2032

Table 24. Global Spatial Transcriptomics Platform Market Share by Region (2027–2032)

Table 25. Spatial Transcriptomics Platform Market Trends

Table 26. Spatial Transcriptomics Platform Market Drivers

Table 27. Spatial Transcriptomics Platform Market Challenges

Table 28. Spatial Transcriptomics Platform Market Restraints

Table 29. Global Spatial Transcriptomics Platform Revenue by Players (US$ Million), 2021–2026

Table 30. Global Spatial Transcriptomics Platform Market Share by Players (2021–2026)

Table 31. Global Top Spatial Transcriptomics Platform Players by Tier (Tier 1, Tier 2, and Tier 3), based on Spatial Transcriptomics Platform Revenue, 2025

Table 32. Ranking of Global Top Spatial Transcriptomics Platform Companies by Revenue (US$ Million) in 2025

Table 33. Global 5 Largest Players Market Share by Spatial Transcriptomics Platform Revenue (CR5 and HHI), 2021–2026

Table 34. Global Key Players of Spatial Transcriptomics Platform, Headquarters and Area Served

Table 35. Global Key Players of Spatial Transcriptomics Platform, Products and Applications

Table 36. Global Key Players of Spatial Transcriptomics Platform, Date of General Availability (GA)

Table 37. Mergers and Acquisitions, Expansion Plans

Table 38. Global Spatial Transcriptomics Platform Market Size by Type (US$ Million), 2021–2026

Table 39. Global Spatial Transcriptomics Platform Revenue Market Share by Type (2021–2026)

Table 40. Global Spatial Transcriptomics Platform Forecasted Market Size by Type (US$ Million), 2027–2032

Table 41. Global Spatial Transcriptomics Platform Revenue Market Share by Type (2027–2032)

Table 42. Global Spatial Transcriptomics Platform Market Size by Application (US$ Million), 2021–2026

Table 43. Global Spatial Transcriptomics Platform Revenue Market Share by Application (2021–2026)

Table 44. Global Spatial Transcriptomics Platform Forecasted Market Size by Application (US$ Million), 2027–2032

Table 45. Global Spatial Transcriptomics Platform Revenue Market Share by Application (2027–2032)

Table 46. North America Spatial Transcriptomics Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. North America Spatial Transcriptomics Platform Market Size by Country (US$ Million), 2021–2026

Table 48. North America Spatial Transcriptomics Platform Market Size by Country (US$ Million), 2027–2032

Table 49. Europe Spatial Transcriptomics Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 50. Europe Spatial Transcriptomics Platform Market Size by Country (US$ Million), 2021–2026

Table 51. Europe Spatial Transcriptomics Platform Market Size by Country (US$ Million), 2027–2032

Table 52. Asia-Pacific Spatial Transcriptomics Platform Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 53. Asia-Pacific Spatial Transcriptomics Platform Market Size by Region (US$ Million), 2021–2026

Table 54. Asia-Pacific Spatial Transcriptomics Platform Market Size by Region (US$ Million), 2027–2032

Table 55. Latin America Spatial Transcriptomics Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 56. Latin America Spatial Transcriptomics Platform Market Size by Country (US$ Million), 2021–2026

Table 57. Latin America Spatial Transcriptomics Platform Market Size by Country (US$ Million), 2027–2032

Table 58. Middle East & Africa Spatial Transcriptomics Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 59. Middle East & Africa Spatial Transcriptomics Platform Market Size by Country (US$ Million), 2021–2026

Table 60. Middle East & Africa Spatial Transcriptomics Platform Market Size by Country (US$ Million), 2027–2032

Table 61. 10x Genomics Company Details

Table 62. 10x Genomics Business Overview

Table 63. 10x Genomics Spatial Transcriptomics Platform Product

Table 64. 10x Genomics Revenue in Spatial Transcriptomics Platform Business (US$ Million), 2021–2026

Table 65. 10x Genomics Recent Development

Table 66. Bruker Company Details

Table 67. Bruker Business Overview

Table 68. Bruker Spatial Transcriptomics Platform Product

Table 69. Bruker Revenue in Spatial Transcriptomics Platform Business (US$ Million), 2021–2026

Table 70. Bruker Recent Development

Table 71. Vizgen Company Details

Table 72. Vizgen Business Overview

Table 73. Vizgen Spatial Transcriptomics Platform Product

Table 74. Vizgen Revenue in Spatial Transcriptomics Platform Business (US$ Million), 2021–2026

Table 75. Vizgen Recent Development

Table 76. STOmics Company Details

Table 77. STOmics Business Overview

Table 78. STOmics Spatial Transcriptomics Platform Product

Table 79. STOmics Revenue in Spatial Transcriptomics Platform Business (US$ Million), 2021–2026

Table 80. STOmics Recent Development

Table 81. Curio Bioscience Company Details

Table 82. Curio Bioscience Business Overview

Table 83. Curio Bioscience Spatial Transcriptomics Platform Product

Table 84. Curio Bioscience Revenue in Spatial Transcriptomics Platform Business (US$ Million), 2021–2026

Table 85. Curio Bioscience Recent Development

Table 86. Resolve Biosciences Company Details

Table 87. Resolve Biosciences Business Overview

Table 88. Resolve Biosciences Spatial Transcriptomics Platform Product

Table 89. Resolve Biosciences Revenue in Spatial Transcriptomics Platform Business (US$ Million), 2021–2026

Table 90. Resolve Biosciences Recent Development

Table 91. Bio-Techne Company Details

Table 92. Bio-Techne Business Overview

Table 93. Bio-Techne Spatial Transcriptomics Platform Product

Table 94. Bio-Techne Revenue in Spatial Transcriptomics Platform Business (US$ Million), 2021–2026

Table 95. Bio-Techne Recent Development

Table 96. Miltenyi Biotec Company Details

Table 97. Miltenyi Biotec Business Overview

Table 98. Miltenyi Biotec Spatial Transcriptomics Platform Product

Table 99. Miltenyi Biotec Revenue in Spatial Transcriptomics Platform Business (US$ Million), 2021–2026

Table 100. Miltenyi Biotec Recent Development

Table 101. SeekGene Company Details

Table 102. SeekGene Business Overview

Table 103. SeekGene Spatial Transcriptomics Platform Product

Table 104. SeekGene Revenue in Spatial Transcriptomics Platform Business (US$ Million), 2021–2026

Table 105. SeekGene Recent Development

Table 106. BMKMANU Company Details

Table 107. BMKMANU Business Overview

Table 108. BMKMANU Spatial Transcriptomics Platform Product

Table 109. BMKMANU Revenue in Spatial Transcriptomics Platform Business (US$ Million), 2021–2026

Table 110. BMKMANU Recent Development

Table 111. CapitalBio Technology Company Details

Table 112. CapitalBio Technology Business Overview

Table 113. CapitalBio Technology Spatial Transcriptomics Platform Product

Table 114. CapitalBio Technology Revenue in Spatial Transcriptomics Platform Business (US$ Million), 2021–2026

Table 115. CapitalBio Technology Recent Development

Table 116. Dynamic Biosystems Company Details

Table 117. Dynamic Biosystems Business Overview

Table 118. Dynamic Biosystems Spatial Transcriptomics Platform Product

Table 119. Dynamic Biosystems Revenue in Spatial Transcriptomics Platform Business (US$ Million), 2021–2026

Table 120. Dynamic Biosystems Recent Development

Table 121. M20 Genomics Company Details

Table 122. M20 Genomics Business Overview

Table 123. M20 Genomics Spatial Transcriptomics Platform Product

Table 124. M20 Genomics Revenue in Spatial Transcriptomics Platform Business (US$ Million), 2021–2026

Table 125. M20 Genomics Recent Development

Table 126. Singleron Biotechnologies Company Details

Table 127. Singleron Biotechnologies Business Overview

Table 128. Singleron Biotechnologies Spatial Transcriptomics Platform Product

Table 129. Singleron Biotechnologies Revenue in Spatial Transcriptomics Platform Business (US$ Million), 2021–2026

Table 130. Singleron Biotechnologies Recent Development

Table 131. AtlasXomics Company Details

Table 132. AtlasXomics Business Overview

Table 133. AtlasXomics Spatial Transcriptomics Platform Product

Table 134. AtlasXomics Revenue in Spatial Transcriptomics Platform Business (US$ Million), 2021–2026

Table 135. AtlasXomics Recent Development

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

Table 139. Authors List of This Report

List of Figures

Figure 1. Spatial Transcriptomics Platform Picture

Figure 2. Global Spatial Transcriptomics Platform Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Spatial Transcriptomics Platform Market Share by Type: 2025 vs 2032

Figure 4. Sequencing-Based Spatial Barcoding Platforms Features

Figure 5. Imaging-Based in Situ Hybridization Platforms Features

Figure 6. In Situ Sequencing Platforms Features

Figure 7. Region-of-Interest Digital Profiling Platforms Features

Figure 8. Spatial Single-Nucleus Sequencing Platforms Features

Figure 9. Other or Hybrid Platforms Features

Figure 10. Global Spatial Transcriptomics Platform Market Size Comparison by Spatial Resolution (US$ Million), 2021–2032

Figure 11. Region-Level Resolution (>100 μm) Features

Figure 12. Spot-Level Resolution (20–100 μm) Features

Figure 13. Near-Cellular Resolution (5–<20 μm) Features

Figure 14. Single-Cell Resolution (1–<5 μm) Features

Figure 15. Subcellular Resolution (<1 μm) Features

Figure 16. Global Spatial Transcriptomics Platform Market Size Comparison by Transcriptome Coverage (US$ Million), 2021–2032

Figure 17. Whole-Transcriptome Profiling Features

Figure 18. Large Targeted Panels (≥1,000 Genes) Features

Figure 19. Medium Targeted Panels (100–999 Genes) Features

Figure 20. Small Targeted Panels (<100 Genes) Features

Figure 21. Global Spatial Transcriptomics Platform Market Size by Application (US$ Million), 2021–2032

Figure 22. Global Spatial Transcriptomics Platform Market Share by Application: 2025 vs 2032

Figure 23. Oncology Research Case Studies

Figure 24. Neuroscience Research Case Studies

Figure 25. Developmental and Regenerative Biology Case Studies

Figure 26. Immunology and Infectious Disease Case Studies

Figure 27. Organ Physiology and Metabolic Disease Case Studies

Figure 28. Other Life Science Research Case Studies

Figure 29. Spatial Transcriptomics Platform Report Years Considered

Figure 30. Global Spatial Transcriptomics Platform Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 31. Global Spatial Transcriptomics Platform Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 32. Global Spatial Transcriptomics Platform Market Share by Region: 2025 vs 2032

Figure 33. Global Spatial Transcriptomics Platform Market Share by Players in 2025

Figure 34. Global Spatial Transcriptomics Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 35. The Top 10 and 5 Players Market Share by Spatial Transcriptomics Platform Revenue in 2025

Figure 36. North America Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. North America Spatial Transcriptomics Platform Market Share by Country (2021–2032)

Figure 38. United States Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Canada Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Europe Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Europe Spatial Transcriptomics Platform Market Share by Country (2021–2032)

Figure 42. Germany Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. France Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. U.K. Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Italy Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Russia Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Ireland Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Asia-Pacific Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Asia-Pacific Spatial Transcriptomics Platform Market Share by Region (2021–2032)

Figure 50. China Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Japan Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. South Korea Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Southeast Asia Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. India Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. Australia & New Zealand Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Latin America Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. Latin America Spatial Transcriptomics Platform Market Share by Country (2021–2032)

Figure 58. Mexico Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 59. Brazil Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 60. Middle East & Africa Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 61. Middle East & Africa Spatial Transcriptomics Platform Market Share by Country (2021–2032)

Figure 62. Israel Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 63. Saudi Arabia Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 64. UAE Spatial Transcriptomics Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 65. 10x Genomics Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021–2026)

Figure 66. Bruker Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021–2026)

Figure 67. Vizgen Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021–2026)

Figure 68. STOmics Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021–2026)

Figure 69. Curio Bioscience Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021–2026)

Figure 70. Resolve Biosciences Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021–2026)

Figure 71. Bio-Techne Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021–2026)

Figure 72. Miltenyi Biotec Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021–2026)

Figure 73. SeekGene Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021–2026)

Figure 74. BMKMANU Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021–2026)

Figure 75. CapitalBio Technology Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021–2026)

Figure 76. Dynamic Biosystems Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021–2026)

Figure 77. M20 Genomics Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021–2026)

Figure 78. Singleron Biotechnologies Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021–2026)

Figure 79. AtlasXomics Revenue Growth Rate in Spatial Transcriptomics Platform Business (2021–2026)

Figure 80. Bottom-up and Top-down Approaches for This Report

Figure 81. Data Triangulation

Figure 82. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Spatial Transcriptomics Platform market? zhanKai

The top companies in the global Spatial Transcriptomics Platform market are 10x Genomics、Bruker、Vizgen.

What is the annual compound growth rate of the global Spatial Transcriptomics Platform market size from 2026 to 2032? shouQi

What was the global market size of Spatial Transcriptomics Platform in 2032? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Spatial Transcriptomics Platform in 2026? shouQi

Related Reports

Spatial Transcriptomics Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Spatial Transcriptomics Platform was estimated to be worth US$ 455 million in 2025 and is projected to reach US$ 1185 million, growing at a CAGR of 14.6% from 2026 to 2032.
Published Date: 2026-07-18
Pages: 115
USD 3950.00
(Single User License)
Global Spatial Transcriptomics Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Spatial Transcriptomics Platform market size was US$ 455 million in 2025 and is forecast to reach a readjusted size of US$ 1185 million by 2032 with a CAGR of 14.6% during the forecast period 2026-2032.
Published Date: 2026-07-18
Pages: 116
USD 4250.00
(Single User License)
Global Spatial Transcriptomics Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spatial Transcriptomics Platform market is projected to grow from US$ 455 million in 2025 to US$ 1185 million by 2032, at a CAGR of 14.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-18
Pages: 141
USD 4900.00
(Single User License)

Spatial Transcriptomics Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Spatial Transcriptomics Platform was estimated to be worth US$ 455 million in 2025 and is projected to reach US$ 1185 million, growing at a CAGR of 14.6% from 2026 to 2032.
Published: 2026-07-18
Pages: 115
USD 3950.00 (Single User License)
Global Spatial Transcriptomics Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Spatial Transcriptomics Platform market size was US$ 455 million in 2025 and is forecast to reach a readjusted size of US$ 1185 million by 2032 with a CAGR of 14.6% during the forecast period 2026-2032.
Published: 2026-07-18
Pages: 116
USD 4250.00 (Single User License)
Global Spatial Transcriptomics Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spatial Transcriptomics Platform market is projected to grow from US$ 455 million in 2025 to US$ 1185 million by 2032, at a CAGR of 14.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-18
Pages: 141
USD 4900.00 (Single User License)